Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors
Authors:
- Min Kyung LeeMLMin Kyung Lee
- Ze ZhangZZZe Zhang
- Kartik SehgalKSKartik Sehgal
- Rondi ButlerRBRondi Butler
- Hannah StolrowHSHannah Stolrow
- Keisuke ShiraiKSKeisuke Shirai
- Devin C KoestlerDKDevin C Koestler
- Lucas A SalasLSLucas A Salas
- John K WienckeJWJohn K Wiencke
- Robert HaddadRHRobert Haddad
- Karl T KelseyKKKarl T Kelsey
Open Access
- 17 May 2024
- journal article
- research article
- Published by Taylor & Francis in Epigenomics
- Vol. 16 (11-12) , 799-807
Abstract
Aim: This study addresses the challenge of predicting the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy.Methods: Using DNA methylation cytometry, we analyzed the immune profiles of six HNSCC patients who showed a positive response to immunotherapy over a year without disease progression.Results: There was an initial increase in CD8 T memory cells and natural killer cells during the first four cycles of immunotherapy, which then returned to baseline levels after a year. Baseline CD8 T cell levels were lower in HNSCC immunotherapy responders but became similar to those in healthy subjects after immunotherapy.Conclusion: These findings suggest that monitoring fluctuations in immune profiles could potentially identify biomarkers for immunotherapy response in HNSCC patients.Keywords
Funding Information
- National Cancer Institute (5R01CA253976-03)
This publication has 35 references indexed in Scilit:
- Biomarkers of response to PD-1 pathway blockadeBritish Journal of Cancer, 2022
- Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volumeClinical and Translational Radiation Oncology, 2021
- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T CellsImmunity, 2019
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyThe Lancet, 2019
- The consecutive disparity index, D: a measure of temporal variability in ecological studiesEcosphere, 2018
- The proportion of circulating CD45RO + CD8 + memory T cells is correlated with clinical response in melanoma patients treated with ipilimumabEuropean Journal of Cancer, 2017
- Epidemiology of Head and Neck CancerSurgical Oncology Clinics of North America, 2015
- High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancerMedical Oncology, 2013
- Biological and methodological variation of lymphocyte subsets in blood of human adultsJournal of Immunological Methods, 2007
- A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables.Psychological Methods, 2006